| Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883) |
|---|
| 03/29/2011 | US7915413 Compounds |
| 03/29/2011 | US7915293 Carbocyclic and heterocyclic sulfonamide derivatives, e.g., N-(2-bromo-5-(trifluoromethoxy)phenyl)-3,5-dichloro-4-(2-chloro-4-nitrophenoxy)benzenesulfonamide and 4-(2-(trifluoromethyl)phenoxy)-1-(3-trifluoromethyl)phenylsulfonyl)piperidine; treating proliferative diseases |
| 03/29/2011 | US7914905 π-conjugated aromatic ring-containing compound and organic electroluminescent device |
| 03/29/2011 | CA2580843C Control of parasites in animals by the use of trifluoromethanesulfonanilide oxime ether derivatives |
| 03/29/2011 | CA2489276C Tricyclic steroid hormone nuclear receptor modulators |
| 03/29/2011 | CA2474208C Astaxanthin esters |
| 03/24/2011 | WO2011034962A2 Compounds that modulate intracellular calcium |
| 03/24/2011 | WO2011034071A1 Process for production of oxidation reaction product of aromatic compound |
| 03/24/2011 | WO2011033366A2 Process for the preparation of duloxetine hydrochloride and its precursors |
| 03/24/2011 | WO2010149363A3 Pharmaceutical composition comprising rotigotine salts (acid or na), especially for iontophoresis |
| 03/24/2011 | US20110071207 Oligomer-Aryloxy-Substituted Propanamine Conjugates |
| 03/24/2011 | US20110071199 Thiophenyl Sulfonamides for the Treatment of Alzheimer's Disease |
| 03/24/2011 | US20110070299 Delayed release pharmaceutical composition of duloxetine |
| 03/23/2011 | EP2298756A1 Method for producing 3-methyl-2-thiophenecarboxylic acid |
| 03/23/2011 | EP2297128A1 Inhibitors of ikk- serine-threonine protein kinase |
| 03/23/2011 | EP2297102A1 Heteroaromatic monoamides as orexinin receptor antagonists |
| 03/23/2011 | EP2297085A2 Substituted arylcyclopentenes as therapeutic agents |
| 03/23/2011 | EP2297084A1 Therapeutic compounds |
| 03/23/2011 | CN101987842A Method for preparing 2-methyl thiophene derivatives |
| 03/22/2011 | US7910770 3-Isopropoxy-7-methoxy-N-(1H-1,2,3,4-tetrazol-5-yl)-1-benzo[b]thiophene-2-carboxamide; autoimmune diseases such as rheumatoid arthritis, immune thrombocytopenia purpura, systemic lupus erythematosus and Crohn's disease |
| 03/22/2011 | US7910762 mixing a pentavalent niobium compound and a tetraol having an optically active binapthol; catalysts for the following asymmetric reactions: Mannich, epoxide ring opening, allylation, cyanation, and alkylation; reacting silicon enolate with imine to form beta-aminocarbonyl compound |
| 03/22/2011 | US7910748 Thiophene-containing compound and thiophene-containing compound polymer, organic electroluminescent device, production method thereof, and image display medium |
| 03/22/2011 | US7910626 Use of S1P receptor agonists in heart diseases |
| 03/22/2011 | CA2622334C Thiophene derivatives for the treatment of diabetes |
| 03/22/2011 | CA2432572C Oxybenzamides derivatives as factor xa inhibitors |
| 03/17/2011 | US20110065782 Methods of identifying compounds that inhibit the activation of a biomolecule and methods of treatment using the compounds |
| 03/17/2011 | US20110065760 Compounds for the inhibition of rotamases and use thereof |
| 03/17/2011 | US20110065724 Compounds that modulate intracellular calcium |
| 03/16/2011 | EP2295402A2 Antibacterial agents |
| 03/16/2011 | CN101985438A Substituted phenyl piperazinyl aralkylone derivatives and application thereof to preparation of analgesics |
| 03/15/2011 | US7906653 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 03/15/2011 | US7906552 Compounds for prodrug for bonding, using prostaglandins |
| 03/15/2011 | US7906537 Substituted p-diaminobenzene derivatives |
| 03/15/2011 | US7906235 Pentacyclic anion salts or tetrazapentalene derivatives and their uses as ionic conducting materials |
| 03/15/2011 | CA2458266C Substituted urea retinoid agonists ii |
| 03/15/2011 | CA2379575C Pharmaceutically active sulfonamide derivatives |
| 03/10/2011 | WO2011028827A2 Organic electronic devices and polymers, including photovoltaic cells and diketone-based polymers |
| 03/10/2011 | WO2011026781A1 Novel multifunctional peptidase inhibitors, especially for medical use |
| 03/10/2011 | WO2011026449A1 A method of crystallization of (s)-n-methyl-3-(1-naphthyloxy)-3- (2-thienyl)propylamine hydrochloride (duloxetine) |
| 03/10/2011 | WO2011026318A1 S-5-substituent-n-2'-(thiophene-2-yl)ethyl-tetralin-2-amine or chiral acid salts thereof and use for preparing rotigotine |
| 03/10/2011 | US20110059999 Hydroxymethylcyclohexylamines |
| 03/10/2011 | US20110059939 Therapeutic compounds |
| 03/10/2011 | CA2772975A1 Novel multifunctional peptidase inhibitors, especially for medical use |
| 03/09/2011 | EP2292611A1 Novel thiophenediamine derivative having urea structure |
| 03/09/2011 | EP2292596A2 CETP activity inhibitor |
| 03/09/2011 | EP2292592A1 Sulfonamide compound and application thereof |
| 03/09/2011 | EP2292589A1 Novel multifunctional peptidase inhibitors, especially for medical use |
| 03/09/2011 | EP2292586A2 Photoelectric conversion material, film containing the material, photoelectric conversion device, production method thereof, photosensor, imaging device and their use methods |
| 03/09/2011 | EP2291353A1 Therapeutic prostaglandin compounds used as ocular hypotensive agents |
| 03/09/2011 | EP2291352A2 N-acylthiourea and n-acylurea inhibitors of the hedgehog protein signalling pathway |
| 03/09/2011 | EP2291346A2 Therapeutic substituted cyclopentanes |
| 03/09/2011 | EP2291345A1 Co-crystals of duloxetine and cox-inhibitors for the treatment of pain |
| 03/09/2011 | EP1732920B1 Thiophene derivatives as chk 1 inhibitors |
| 03/08/2011 | US7902394 Calcilytic compounds |
| 03/08/2011 | US7902382 Thiophene-containing compound and thiophene-containing compound polymer, organic electroluminescent device, production method thereof, and image display medium |
| 03/08/2011 | US7902372 Therapy for obesity; using a secondary amino compound |
| 03/08/2011 | CA2640041C New process for the synthesis of strontium ranelate and its hydrates |
| 03/08/2011 | CA2496883C Process for the enantioselective hydrogenation of amino alcohols |
| 03/03/2011 | WO2011024001A1 Np-1 antagonists and their therapeutic use |
| 03/03/2011 | WO2011023864A1 Pseudodipeptides as mmp inhibitors |
| 03/03/2011 | WO2011023791A2 Method for producing organoaluminium compounds and use thereof |
| 03/03/2011 | WO2010145197A8 Novel 6-arylamino pyridone sulfonamides and 6-arylamino pyrazinone sulfonamdies as mek inhibitors |
| 03/03/2011 | WO2008078200A3 Benzenesulfonamide derivatives as hiv protease inhibitors |
| 03/03/2011 | WO2007054776A9 Stilbene like compounds as novel hdac inhibitors |
| 03/03/2011 | US20110053958 Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto |
| 03/03/2011 | US20110053939 Novel aromatic nitro compounds |
| 03/03/2011 | US20110053890 Synthetic analogs of bacterial quorum sensors |
| 03/03/2011 | US20110052732 Mineral absorption accelerator and iron deficiency anemia improver of food composition |
| 03/03/2011 | US20110052643 Compounds for inflammation and immune-related uses |
| 03/03/2011 | US20110049427 Thiophene derivatives, and LC media containing same |
| 03/03/2011 | CA2772093A1 Np-1 antagonists and their therapeutic use |
| 03/02/2011 | EP2289965A1 Polymer compound and organic transistor using the polymer compound |
| 03/02/2011 | EP2289876A1 Bis(thio-hydrazide amide) compounds in combination with taxol for treating cancer |
| 03/02/2011 | EP2289871A1 7-substituted tetracycline compounds |
| 03/02/2011 | EP2289521A2 Compositions and methods for use in tergeting vascular destruction |
| 03/02/2011 | EP2288600A1 Substituted arylcyclopentenes as prostaglandin ep2 agonists |
| 03/02/2011 | EP2046748B1 Phenylpentadienoyl derivatives and their use as par 1 antagonists |
| 03/02/2011 | EP1969132B1 Enzymatic reduction for producing optically active alcohols |
| 03/02/2011 | EP1814871B1 Compounds that modulate ppary type receptors, and use thereof in cosmetic or pharmaceutical compositions |
| 03/02/2011 | EP1814848B9 2,3,4-substituted-cyclopentanones as therapeutic agents |
| 03/02/2011 | EP1646608B1 Tricyclic derivatives or pharmaceutically acceptable salts thereof, their preparations and pharmaceutical compositions containing them |
| 03/02/2011 | EP1578715B1 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 03/02/2011 | CN101035760B Compounds which potentiate glutamate receptor and uses thereof in medicine |
| 03/01/2011 | US7897815 Hexafluoroisopropanol derivatives |
| 03/01/2011 | US7897789 Vitamin D receptor modulators |
| 03/01/2011 | US7897647 Useful in extending the in vivo circulating life of biologically active materials; bicine linker allows for the manipulation of the hydrolysis rate of the prodrug, thereby releasing the native entities at various rates in vivo as well as in vitro |
| 03/01/2011 | US7897596 {2-Amino-4-[(4-(4-chlorophenyl)piperidin-1-yl)methyl]thiophen-3-yl}(4-chlorophenyl)methanone; analgesic, antidepressant; cardiac disease or disorder, neurological disease or injury, sleep disorder, epilepsy, neuropathic pain, angina |
| 03/01/2011 | US7897348 Detection of negatively charged polymers using water-soluble, cationic, polythiophene derivatives |
| 02/24/2011 | WO2011021520A1 Aromatic amine derivatives and organic electroluminescent elements using same |
| 02/24/2011 | WO2011020712A2 Oligothiophenes derivatives |
| 02/24/2011 | US20110046380 Method for producing unsaturated organic compound |
| 02/24/2011 | US20110046210 Substituted thiopenecarboxamides as ikk-beta serine-, threonine-protein kinase inhibitors |
| 02/24/2011 | US20110046195 Non-Lactone Carbocyclic and Heterocyclic Antagonists and Agonists of Bacterial Quorum Sensing |
| 02/24/2011 | US20110046147 17beta-hydroxysteroid dehydrogenase type 1 inhibitors for the treatment of hormone-related diseases |
| 02/24/2011 | US20110046146 Phosphodiesterase 4 inhibitors |
| 02/24/2011 | US20110044938 Tetrahydrobenzothiophene derivatives |
| 02/23/2011 | EP2287162A1 Derivatives of 4-piperazin-1-yl-4-benzo[b]thiophene suitable for the treatment of cns disorders |
| 02/23/2011 | EP2287161A1 Derivatives of 4-piperazin-1-yl-4-benzo[b]thiophene suitable for the treatment of cns disorders |
| 02/23/2011 | EP2287141A1 Method for producing unsaturated organic compound |
| 02/23/2011 | EP2285836A1 Photoinitiator mixtures |